GFM
CRMD icon

GF Fund Management’s CorMedix CRMD Stock Holding History

GF Fund Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Sell
1,668
-92
-5% -$727 ﹤0.01% 520
2026
Q1 		$11.9K Buy
1,760
+212
+14% +$1.57K ﹤0.01% 543
2025
Q4 		$18K Sell
1,548
-58
-4% -$641 ﹤0.01% 518
2025
Q3 		$18.7K Buy
1,606
+52
+3% +$629 ﹤0.01% 497
2025
Q2 		$19.1K Hold
1,554
– – ﹤0.01% 507
2025
Q1 		$9.57K Buy
1,554
+280
+22% +$2.9K ﹤0.01% 569
2024
Q4 		$10.3K Buy
+1,274
New +$12.7K ﹤0.01% 541

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GF Fund Management's CRMD Position: Q2 2026 in Review

GF Fund Management reduced its CorMedix (CRMD) stake by 5.2% in Q2 2026, selling an estimated $727 and leaving 1,668 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

GF Fund Management first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $19.1K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • GF Fund Management held 1,668 shares of CorMedix worth $13.1K as of Q2 2026.
  • GF Fund Management sold 92 CorMedix shares in Q2 2026, an estimated $727.
  • CorMedix made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #520 holding.
  • GF Fund Management first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's CorMedix position peaked at $19.1K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.